Precision Medicine Management of Chronic Lymphocytic Leukemia

Precision Medicine Management of Chronic Lymphocytic Leukemia

Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in western countries, with an incidence of approximately 5.1/100,000 new cases per year. Some patients may never require treatment, whereas others relapse early after front line therapeutic approaches. Recent whole genome and who...

Full description

Bibliographic Details
Main Authors: Riccardo Moia, Andrea Patriarca, Mattia Schipani, Valentina Ferri, Chiara Favini, Sruthi Sagiraju, Wael Al Essa, Gianluca Gaidano
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:Cancers
Subjects:
chronic lymphocytic leukemia
target therapy
precision medicine
Online Access:https://www.mdpi.com/2072-6694/12/3/642

Internet

https://www.mdpi.com/2072-6694/12/3/642

Similar Items